Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Capital Goods
Create a narrative
thyssenkrupp nucera KGaA Community
XTRA:NCH2 Community
4
Narratives
written by author
1
Comments
on narratives written by author
82
Fair Values set
on narratives written by author
Create a narrative
thyssenkrupp nucera KGaA
Popular
Undervalued
Overvalued
Community Investing Ideas
thyssenkrupp nucera KGaA
CH
Chris1
Community Contributor
Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth
EBIT-margin trajectory: Historical: 2.3 % → 3.6 % (FY 22/23) , down to – 2 % (FY 23/24) , back to 3 % in Q1 24/25 Forecast: Gradual recovery to 4–6 % by FY 25/26, reaching 6–8 % by FY 29/30 Revenue growth: Historical: + 70 % (FY 22/23) , + 30 % (FY 23/24) , + 27 % (Q1 24/25) Forecast: ~ 15 % CAGR over the next five years (FY 24/25–29/30) Five-year share-price goal: Current fair value: € 8.5–9.0 per share Five-year target: € 14–15 per share (≈ 1.9 bn EUR market cap) Enterprise value (EV) outlook (DCF-based): Revenues rising to ~ 1.8 bn EUR by FY 29/30 EBIT of ~ 145 m EUR (8 % margin) → NOPAT ~ 102 m EUR FCF margin ~ 5 % → ~ 90 m EUR FCF Terminal-value multiple: EV/FCF = 15 → TV ~ 1.35 bn EUR Discounted EV: ≈ 1.18 bn EUR + net cash 0.69 bn EUR → ≈ 1.87 bn EUR → ~ 14.8 EUR/share Top risks: execution delays, margin pressure from competition, raw-material cost swings, subsidy uncertainty, heavy capex needs Narrative Outlook Over the next five years, thyssenkrupp nucera is poised to leverage its unique position at the intersection of mature Chlor-Alkali expertise and rapid Green-Hydrogen adoption. After a transitional phase in FY 23/24 with negative margins driven by upfront investments, the company’s shift toward series-manufactured AWE modules and high-growth project backlog supports a steady margin recovery.
View narrative
€14.40
FV
26.4% undervalued
intrinsic discount
15.00%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
3 months ago
author updated this narrative
thyssenkrupp nucera KGaA
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Progress In Green Hydrogen Projects And Regulatory Support Will Strengthen Future Prospects
Key Takeaways Expanding project execution in Green hydrogen ventures and favorable EU regulations support robust revenue growth and improved margins. R&D and cost management strategies aim to boost technological leadership and maintain profitability despite potential sales slowdowns.
View narrative
€14.18
FV
25.2% undervalued
intrinsic discount
8.63%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
1 day ago
author updated this narrative
thyssenkrupp nucera KGaA
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Regulatory Uncertainty And Overcapacity Will Squeeze Revenues
Key Takeaways Rapid technological shifts and intensified competition in electrolyzer manufacturing pose risks to demand, margins, and potential revenue growth. Policy, funding, and customer concentration uncertainties threaten project conversions, pipeline visibility, and long-term earnings stability.
View narrative
€8.70
FV
21.8% overvalued
intrinsic discount
-10.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
thyssenkrupp nucera KGaA
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Global Decarbonization And Electrolysis Expansion Will Transform Energy Markets
Key Takeaways Accelerated contract wins and rapid European infrastructure growth position the company for outsized sales, margin gains, and market leadership in green hydrogen. Strong financials and technology leadership support sustained earnings growth, recurring revenues, and resilience, making it the preferred partner for major decarbonization projects.
View narrative
€17.00
FV
37.6% undervalued
intrinsic discount
15.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
NCH2
NCH2
thyssenkrupp nucera KGaA
Your Fair Value
€
Current Price
€10.60
3.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
1b
2015
2018
2021
2024
2025
2027
2030
Revenue €1.3b
Earnings €32.8m
Advanced
Set Fair Value